339 / 1068
The Royal Marsden
What is the risk of local
recurrence for node positive
vs negative if CRM is clear
•
For a good quality TME CRM-ve – no
difference – CR07 5-6% LR (Quirke et
al Lancet Oncology) rates irrespective
of node status
•
OCUM trial follow up data...